Department of Biochemistry, College of Oriental Medicine, Dongeui University, Busan 614-052, Republic of Korea.
BMC Complement Altern Med. 2014 Mar 15;14:101. doi: 10.1186/1472-6882-14-101.
Poria cocos Wolf, a medicinal fungus, is widely used in traditional medicines in East Asian countries owing to its various therapeutic potentials. Although several studies have demonstrated the anti-inflammatory activity of this fungus, its underlying mechanisms have not yet been clearly defined.
In the present study, we have demonstrated the anti-inflammatory effects of ethanol extract of P. cocos (EEPC) in lipopolysaccaride (LPS)-stimulated RAW 264.7 macrophages. As inflammatory parameters, the productions of nitric oxide (NO), prostaglandin E2 (PGE2), interleukin (IL)-1β and tumor necrosis factor (TNF)-α were evaluated. We also examined the EEPC's effect on the nuclear factor-kappaB (NF-κB) signaling pathway.
Our results indicated that EEPC exhibits a potent inhibitory effect on NO production and inhibits PGE2 release in LPS-induced macrophages without affecting cell viability. EEPC also significantly attenuated LPS-induced secretion of inflammatory cytokines IL-1β and TNF-α. Additionally, LPS-induced expression of inducible NO synthase (iNOS), cyclooxygenase (COX)-2, IL-1β, and TNF-α was decreased by pre-treatment with EEPC at the transcriptional level. Moreover, EEPC clearly inhibited LPS-induced nuclear translocation of NF-κB p65 subunits, which correlated with EEPC's inhibitory effects on inhibitor kappaB (IκB) degradation. Moreover, EEPC clearly suppressed the LPS-induced DNA-binding activity of NF-κB, as well as the nuclear translocation of the NF-κB p65, which correlated with EEPC's inhibitory effects on inhibitor kappaB (IκB) degradation.
Taken together, our data indicates that EEPC targets the inflammatory response of macrophages via inhibition of iNOS, COX-2, IL-1β, and TNF-α through inactivation of the NF-κB signaling pathway, supporting the pharmacological basis of P. cocos as a traditional herbal medicine for treatment of inflammation and its associated disorders.
药用真菌茯苓在东亚国家的传统药物中被广泛应用,因为它具有多种治疗潜力。尽管已有几项研究表明该真菌具有抗炎活性,但它的潜在机制尚未明确界定。
在本研究中,我们已经证明了茯苓乙醇提取物(EEPC)在脂多糖(LPS)刺激的 RAW 264.7 巨噬细胞中的抗炎作用。作为炎症参数,评估了一氧化氮(NO)、前列腺素 E2(PGE2)、白细胞介素(IL)-1β和肿瘤坏死因子(TNF)-α的产生。我们还检查了 EEPC 对核因子-κB(NF-κB)信号通路的影响。
我们的结果表明,EEPC 对 NO 产生具有强大的抑制作用,并抑制 LPS 诱导的巨噬细胞中 PGE2 的释放,而不影响细胞活力。EEPC 还显著减弱了 LPS 诱导的炎症细胞因子 IL-1β和 TNF-α的分泌。此外,EEPC 在转录水平上降低了 LPS 诱导的诱导型一氧化氮合酶(iNOS)、环氧化酶(COX)-2、IL-1β和 TNF-α的表达。此外,EEPC 明显抑制了 LPS 诱导的 NF-κB p65 亚基的核转位,这与 EEPC 对抑制κB(IκB)降解的抑制作用有关。此外,EEPC 明显抑制了 LPS 诱导的 NF-κB 的 DNA 结合活性,以及 NF-κB p65 的核转位,这与 EEPC 对抑制κB(IκB)降解的抑制作用有关。
综上所述,我们的数据表明,EEPC 通过抑制 iNOS、COX-2、IL-1β和 TNF-α,通过 NF-κB 信号通路失活,靶向巨噬细胞的炎症反应,支持了茯苓作为传统草药治疗炎症及其相关疾病的药理学基础。